Most adults fail to complete the recommended repeat stool testing after their initial stool test, diminishing the benefits of ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. A study finds rural and nonrural patients have similar follow-up times ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard ®) - are equally effective for ...

About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and ...

Patients with a positive fecal immunochemistry test (FIT) were shown to be at significantly greater risk of developing psoriasis than those with FIT-negative tests. The fecal immunochemistry test (FIT ...

Until now, the best way to diagnose colorectal cancer, which encompasses colon and rectal cancer, was a colonoscopy. However, the procedure can be invasive as well as uncomfortable for people. But a ...

Stool tests may be more effective than respiratory tests in identifying COVID-19 infections in children and infants since they carry a higher viral load in their stool than adults, researchers at the ...